Skip to main content

Ethylmorphine Facts

Opioid; Depressant; Substituted morphinan; Mu-opioid receptor agonist

Description

Ethylmorphine (codethyline) — also known as dionine — is a semi-synthetic opioid of the morphinan class. The liver converts it to morphine, which activates opioid receptors and produces the pain suppression and sedation characteristic of the opioid class.

Subjective effects include pain relief, warmth, bodily heaviness, mild euphoria, sedation, and anxiolysis. The experience is gentler than morphine — onset is gradual and the ceiling lower, reflecting the metabolic bottleneck of liver conversion.

Ethylmorphine produces physical dependence with regular use, and the fatal blood concentration is roughly nine times the level found in impaired drivers.[1][2] Genetics determine how much morphine the body makes from a given dose,[3] and combining with alcohol creates a dual-mechanism lethal risk.[4]

Dose and durationby route · individual sensitivity varies

Oral(mg)
Threshold< 20 mgLight40 – 50 mgCommon50 – 100 mgStrong100 – 200 mgHeavy200+ mg

Starts in 20 – 45 minLasts 4 – 5 hoursAfter-effects 2 – 6 hours

Body and dependence

Acute toxicity
Moderate
Chronic toxicity
Moderate
Physical dependence
High
Psychological dependence
High
Withdrawal
Moderate · medical supervision
Compulsive redosing
Moderate

Tolerance

Builds
Moderate
Fully resets after
1.5 weeks
Carries over to
morphine; codeine; oxycodone; hydrocodone; heroin; all mu-opioid agonists

Effectslikely at a common dose

Perception
none likely · 4 possible, including Spatial disorientation, Visual acuity suppression
Body
Muscle relaxation; Body high; Constipation; Pain suppression; Pupil constriction; Sedation; +16 possible, including Respiratory depression, Dizziness, Motor control impairment
Thinking
none likely · 15 possible, including Cognitive impairment, Analysis suppression, Decision impairment
Self
none likely · 5 possible, including Craving, Social disconnection, Communication suppression
Time
none likely · 2 possible, including Temporal disorientation

Who shouldn't take it

Absolute
Respiratory insufficiency; Head injury or raised intracranial pressure; Pediatric patients under 8 years; Concurrent CNS depressant use; Intravenous administration; Paralytic ileus
Relative
Hepatic impairment; CYP2D6 ultrarapid metabolizer status

Combinations62 recorded

Lethal (6)
Benzodiazepines, Barbiturates; GHB, Baclofen; GHB, GBL; Ketamine; Local anesthetics; Tramadol
Dangerous (28)
Alpha-2 adrenergic receptor antagonist; Amphetamines; Anticholinergics; Antihistamines; Antipsychotics; Benzodiazepines; Buprenorphine, Kratom; Cannabis, THC; Clonidine, Guanfacine; Gabapentin, Pregabalin; MAOIs; MDMA, Amphetamines; MDMA, MDA; Naltrexone; NRIs; SNRIs; SSRIs; Stimulants; Synthetic cannabinoids; THC; Caffeine; CBD; Glutamate modulator; Huperzine A; and 4 more, see full page
Caution (19)
See full page: psychedex.org/substances/ethylmorphine
Not graded (9)
Not listed never means safe.

Seek help immediately if

  • Unresponsive / can't be woken, even to a firm sternal rub
  • Slow, shallow, or stopped breathing
  • Pinpoint pupils
  • Blue/grey lips, fingertips, or skin (cyanosis)
  • Limp body; pale, clammy skin
  • Choking or gurgling sounds ("death rattle")
  • Slow, erratic, or absent pulse

What to do

  1. Try to wake them — shout their name, firm sternal rub
  2. Call emergency services immediately
  3. Administer naloxone if available
  4. Give rescue breaths (or CPR if there is no pulse)
  5. Place them in the recovery position
  6. Stay with them; re-dose naloxone every 2–3 minutes if there is no response
Reversal agent
Naloxone (Narcan) — opioid antagonist. May require repeated doses; its effect can wear off before the opioid does.

With prompt naloxone and rescue breathing, reversal is usually rapid. Because naloxone can wear off before the opioid — especially with long-acting opioids (methadone) or high-potency ones (fentanyl) — a period of monitoring is needed even after the person revives.

988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE

Version r1.a1 · Not medical advice

References

  1. [1]
    ^Kintz P, Jamey C, Mangin P (1994) Ethylmorphine concentrations in human samples in an overdose case — Archives of Toxicology PMID:8024470
  2. [2]
    ^Jones AW, Holmgren A, Kugelberg FC (2008) Driving under the influence of opiates: concentration relationships between morphine, codeine, 6-acetyl morphine, and ethyl morphine in blood — Journal of Analytical Toxicology PMID:18430293
  3. [3]
    ^Hedenmalm K, Sundgren M, Granberg K, Spigset O, Dahlqvist R (1997) Urinary excretion of codeine, ethylmorphine, and their metabolites: relation to the CYP2D6 activity — Therapeutic Drug Monitoring PMID:9421105
  4. [4]
    ^Xu BQ, Aasmundstad TA, Lillekjendlie B, Bjørneboe A, Christophersen AS, Mørland J (1997) Effects of ethanol on ethylmorphine metabolism in isolated rat hepatocytes: characterization by means of a multicompartmental model — Pharmacology & Toxicology PMID:9140136
Print version
Report an issue